Long‐term outcomes of patients with obscure gastrointestinal bleeding after negative capsule endoscopy
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16379 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Issei Hirata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Capsule Endoscopy, Hemostasis, Endoscopic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Although small‐bowel capsule endoscopy (CE) is widely used for obscure gastrointestinal bleeding (OGIB), long‐term outcomes for OGIB patients after negative CE remain unclear. Herein, we defined negative CE as P0 (no bleeding potential) or P1 (less likely to bleed), based on the P classification using CE. We aimed to clarify long‐term outcomes of patients with OGIB after negative CE.
Methods
This single‐center observational study enrolled 461 consecutive patients with OGIB who underwent CE from March 2014 to October 2021 and were followed up for >1 year. We examined rebleeding rates and predictive factors.
Results
Two hundred and twenty‐four (49%) patients had P0, and 237 (51%) had P1 findings. Rebleeding occurred in 9% and 16% of patients in the P0 and P1 groups, respectively. Two patients in the P0 group and 15 in the P1 group showed rebleeding from the small bowel. The rate of small‐bowel rebleeding was significantly lower in the P0 group than that in the P1 group (1% vs 6%, P = 0.002), as was the cumulative rebleeding rate ( P = 0.004). In the multivariate analysis, history of endoscopic hemostasis (hazard ratio [HR] = 15.958, 95% confidence interval [CI]:4.950–51.447, P < 0.001) and P1 CE findings (HR = 9.989, 95% CI: 2.077–48.030, P = 0.004) were independently predicted small‐bowel rebleeding.
Conclusions
OGIB with P0 CE findings rarely showed rebleeding from the small bowel. Rebleeding may occur in patients with OGIB. Patients with history of endoscopic hemostasis for small‐bowel lesions or P1 CE findings should be followed up intensively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Gastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, Hiroshima, Japan.
ORCID-Profile: Issei Hirata, Akiyoshi Tsuboi, Hidenori Tanaka, Hidehiko Takigawa, Yuji Urabe, Shiro Oka
Zitieren
APA
Hirata, I., Tsuboi, A., Matsubara, Y., Sumioka, A., Takasago, T., Tanaka, H., Yamashita, K., Takigawa, H., Kotachi, T., Yuge, R., Urabe, Y., & Oka, S. (2024). Long‐term outcomes of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16379
Vancouver
Hirata I, Tsuboi A, Matsubara Y, Sumioka A, Takasago T, Tanaka H, et al. Long‐term outcomes of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16379
BibTeX
@article{Hirata2024,
author = {Hirata, Issei and Tsuboi, Akiyoshi and Matsubara, Yuka and Sumioka, Akihiko and Takasago, Takeshi and Tanaka, Hidenori and Yamashita, Ken and Takigawa, Hidehiko and Kotachi, Takahiro and Yuge, Ryo and Urabe, Yuji and Oka, Shiro},
title = {Long‐term outcomes of patients with obscure gastrointestinal bleeding after negative capsule endoscopy},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16379}
}
EUVIMED